Abstract
Phyllanthus species for patients with chronic hepatitis B virus (HBV) infection have been assessed in clinical trials, but no consensus regarding their usefulness exists. When compared with placebo or no intervention, we were unable to identify convincing evidence that phyllanthus species are beneficial in patients with chronic hepatitis B. Some randomised clinical trials have compared phyllanthus species versus antiviral drugs.
| Original language | English |
|---|---|
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 4 |
| Pages (from-to) | CD009004 |
| ISSN | 1469-493X |
| DOIs | |
| Publication status | Published - 2013 |